Molecular diagnosis and monitoring in the clinical management of patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors
J Ou, JA Vergilio, A Bagg - American journal of hematology, 2008 - Wiley Online Library
The well‐established molecular pathogenesis of chronic myelogenous leukemia (CML) and
its consequences for laboratory testing and clinical management illustrate a classic …
its consequences for laboratory testing and clinical management illustrate a classic …
Molecular diagnosis and monitoring in the clinical management of patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors.
J Ou, JA Vergilio, A Bagg - American Journal of Hematology, 2008 - europepmc.org
The well-established molecular pathogenesis of chronic myelogenous leukemia (CML) and
its consequences for laboratory testing and clinical management illustrate a classic …
its consequences for laboratory testing and clinical management illustrate a classic …
Molecular diagnosis and monitoring in the clinical management of patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors
J Ou, JA Vergilio, A Bagg - American journal of …, 2008 - pubmed.ncbi.nlm.nih.gov
The well-established molecular pathogenesis of chronic myelogenous leukemia (CML) and
its consequences for laboratory testing and clinical management illustrate a classic …
its consequences for laboratory testing and clinical management illustrate a classic …
[引用][C] Molecular diagnosis and monitoring in the clinical management of patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors
J OU, JA VERGILIO, A BAGG - American journal of …, 2008 - pascal-francis.inist.fr
Molecular diagnosis and monitoring in the clinical management of patients with chronic
myelogenous leukemia treated with tyrosine kinase inhibitors CNRS Inist Pascal-Francis …
myelogenous leukemia treated with tyrosine kinase inhibitors CNRS Inist Pascal-Francis …